These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 21548090)

  • 1. Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.
    Ray S; Reddy PJ; Jain R; Gollapalli K; Moiyadi A; Srivastava S
    Proteomics; 2011 Jun; 11(11):2139-61. PubMed ID: 21548090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical points in urinary proteomics.
    Thongboonkerd V
    J Proteome Res; 2007 Oct; 6(10):3881-90. PubMed ID: 17824635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics.
    Lee HJ; Lee EY; Kwon MS; Paik YK
    Curr Opin Chem Biol; 2006 Feb; 10(1):42-9. PubMed ID: 16418010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma-derived microparticles for biomarker discovery.
    Smalley DM; Ley K
    Clin Lab; 2008; 54(3-4):67-79. PubMed ID: 18630736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechniques in proteomics: current status, promises and challenges.
    Ray S; Chandra H; Srivastava S
    Biosens Bioelectron; 2010 Jul; 25(11):2389-401. PubMed ID: 20451366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary proteomics in biomedical research.
    Zhang A; Sun H; Wang P; Wang X
    Clin Chim Acta; 2013 Jan; 415():261-5. PubMed ID: 23146870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proteomic advantage: label-free quantification of proteins expressed in bovine milk during experimentally induced coliform mastitis.
    Boehmer JL; DeGrasse JA; McFarland MA; Tall EA; Shefcheck KJ; Ward JL; Bannerman DD
    Vet Immunol Immunopathol; 2010 Dec; 138(4):252-66. PubMed ID: 21067814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR; Liotta LA; Petricoin EF
    Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaching clinical proteomics: current state and future fields of application in cellular proteomics.
    Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tárnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Wagener C; Wagner O; Schmitz G
    Cytometry A; 2009 Oct; 75(10):816-32. PubMed ID: 19739086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in selected reaction monitoring MS-driven plasma protein biomarker analysis.
    Chiu CL; Randall S; Molloy MP
    Bioanalysis; 2009 Jul; 1(4):847-55. PubMed ID: 21083142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry.
    Ahmed FE
    J Sep Sci; 2009 Mar; 32(5-6):771-98. PubMed ID: 19219839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human saliva proteome analysis.
    Hu S; Loo JA; Wong DT
    Ann N Y Acad Sci; 2007 Mar; 1098():323-9. PubMed ID: 17435138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of urinary proteomics in biomarker discovery.
    Shao C; Wang Y; Gao Y
    Sci China Life Sci; 2011 May; 54(5):409-17. PubMed ID: 21455690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in proximal fluid proteomics for disease biomarker discovery.
    Teng PN; Bateman NW; Hood BL; Conrads TP
    J Proteome Res; 2010 Dec; 9(12):6091-100. PubMed ID: 21028795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced proteomic technologies for cancer biomarker discovery.
    Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
    Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards the application of proteomics in renal disease diagnosis.
    Vidal BC; Bonventre JV; I-Hong Hsu S
    Clin Sci (Lond); 2005 Nov; 109(5):421-30. PubMed ID: 16232126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin chromatography to deplete high-abundance proteins for serum proteomics.
    Lei T; He QY; Wang YL; Si LS; Chiu JF
    Clin Chim Acta; 2008 Feb; 388(1-2):173-8. PubMed ID: 18036563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum low-molecular-weight protein fractionation for biomarker discovery.
    VanMeter AJ; Camerini S; Polci ML; Tessitore A; Trivedi N; Heiby M; Kamal Y; Hansen J; Zhou W
    Methods Mol Biol; 2012; 823():237-49. PubMed ID: 22081349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunities for sensitive plasma proteome analysis.
    Landegren U; Vänelid J; Hammond M; Nong RY; Wu D; Ullerås E; Kamali-Moghaddam M
    Anal Chem; 2012 Feb; 84(4):1824-30. PubMed ID: 22248085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.